Ma D - Search Results

1

Calnexin Impairs the Antitumor Immunity of CD4⁺ and CD8⁺ T Cells.

Chen Y, Ma D, Wang X, Fang J, Liu X, Song J, Li X, Ren X, Li Q, Li Q, Wen S, Luo L, Xia J, Cui J, Zeng G, Chen L, Cheng B, Wang Z. Chen Y, et al. Among authors: ma d. Cancer Immunol Res. 2019 Jan;7(1):123-135. doi: 10.1158/2326-6066.CIR-18-0124. Epub 2018 Nov 6. Cancer Immunol Res. 2019. PMID: 30401678

2

Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.

Song JJ, Zhao SJ, Fang J, Ma D, Liu XQ, Chen XB, Wang Y, Cheng B, Wang Z. Song JJ, et al. Among authors: ma d. BMC Cancer. 2016 Jul 26;16:530. doi: 10.1186/s12885-016-2419-6. BMC Cancer. 2016. PMID: 27457382 Free PMC article.

3

Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.

Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, Lui VWY, Xia J, Cheng B, Wang Z. Fang J, et al. Among authors: ma d. BMC Cancer. 2017 May 26;17(1):375. doi: 10.1186/s12885-017-3317-2. BMC Cancer. 2017. PMID: 28549420 Free PMC article.

4

High level of calpain1 promotes cancer cell invasion and migration in oral squamous cell carcinoma.

Ma D, Fang J, Liu Y, Song JJ, Wang YQ, Xia J, Cheng B, Wang Z. Ma D, et al. Oncol Lett. 2017 Jun;13(6):4017-4026. doi: 10.3892/ol.2017.5970. Epub 2017 Apr 3. Oncol Lett. 2017. PMID: 28588694 Free PMC article.

5

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

Chen Y, Li Q, Li X, Ma D, Fang J, Luo L, Liu X, Wang X, Lui VWY, Xia J, Cheng B, Wang Z. Chen Y, et al. Among authors: ma d. Oncoimmunology. 2017 Nov 6;7(2):e1388484. doi: 10.1080/2162402X.2017.1388484. eCollection 2018. Oncoimmunology. 2017. PMID: 29308315 Free PMC article.

6

Thrombomodulin (TM) in tumor cell differentiation and periphery blood immune microenvironment in oral squamous cell carcinoma.

Song J, Ma D, Liu X, Chen Y, Fang J, Lui VWY, Zhao S, Xia J, Cheng B, Wang Z. Song J, et al. Among authors: ma d. Clin Immunol. 2018 Jun;191:27-33. doi: 10.1016/j.clim.2018.02.011. Epub 2018 Mar 18. Clin Immunol. 2018. PMID: 29562205

7

Mesenchymal stem cells participate in oral mucosa carcinogenesis by regulating T cell proliferation.

Chen Y, Wang X, Fang J, Song J, Ma D, Luo L, He B, Xia J, Lui VWY, Cheng B, Wang Z. Chen Y, et al. Among authors: ma d. Clin Immunol. 2019 Jan;198:46-53. doi: 10.1016/j.clim.2018.12.001. Epub 2018 Dec 4. Clin Immunol. 2019. PMID: 30528889

8

Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.

Chen Y, Wang J, Wang X, Li X, Song J, Fang J, Liu X, Liu T, Wang D, Li Q, Wen S, Ma D, Xia J, Luo L, Zheng SG, Cui J, Zeng G, Chen L, Cheng B, Wang Z. Chen Y, et al. Among authors: ma d. Clin Cancer Res. 2019 Oct 15;25(20):6180-6194. doi: 10.1158/1078-0432.CCR-18-4134. Epub 2019 Jul 26. Clin Cancer Res. 2019. PMID: 31350312

9

Dysfunctional role of elevated TIGIT expression on T cells in oral squamous cell carcinoma patients.

Liu X, Li Q, Zhou Y, He X, Fang J, Lu H, Wang X, Wang D, Ma D, Cheng B, Liao G, Wang Z. Liu X, et al. Among authors: ma d. Oral Dis. 2021 Oct;27(7):1667-1677. doi: 10.1111/odi.13703. Epub 2020 Nov 19. Oral Dis. 2021. PMID: 33125794

10

Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.

Chen Y, Wang J, Wang X, Li X, Song J, Fang J, Liu X, Liu T, Wang D, Li Q, Wen S, Ma D, Xia J, Luo L, Zheng SG, Cui J, Zeng G, Chen L, Cheng B, Wang Z. Chen Y, et al. Among authors: ma d. Clin Cancer Res. 2022 May 13;28(10):2197. doi: 10.1158/1078-0432.CCR-22-1109. Clin Cancer Res. 2022. PMID: 35553648 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,014 results

Search Page